SIROLIMUS - ANVISA Registration 80146501532

Access comprehensive regulatory information for SIROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146501532 and manufactured by manufacturer not specified. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Jul 28, 2033.

This page provides complete technical specifications for 3 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTIC DIVISION, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146501532
3 Related Devices
Registration Details
ANVISA Registration Number: 80146501532
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (3)

ARCHITECT Sirolimus Reagent Kit
Risk Class III

Registration Details

80146501532

25351279325200820

56998701000116

Company Information

Dates and Status

Jul 28, 2008

28/07/2033

09/18/2025 19:00:01

ARCHITECT Sirolimus Reagent Kit
Risk Class III

Registration Details

80146501532

25351279325200820

56998701000116

Company Information

Ireland
PT: IRLANDA

Dates and Status

Jul 28, 2008

28/07/2033

09/18/2025 19:00:01

ARCHITECT Sirolimus Reagent Kit
Risk Class III

Registration Details

80146501532

25351279325200820

56998701000116

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 28, 2008

28/07/2033

09/18/2025 19:00:01